Psychedelic Drug Development Shows Promise, But Market Path Remains Steep

Psychedelics Edge Toward Mainstream

 
• By Sushmita Panda
  
Psilocybin as brain therapy
Psilocybin, a hallucinogenic compound in over 200 mushroom species, is under investigation as a potential therapy. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Market Snapshot

More from Scrip